Tag Archives: epidiolex

The Pharmacology of Cannabis Cannabinoids and Terpenes by Dr. Ethan Russo

Clearly understanding the basics to pharmacokinetics: Extracts from The Cannabis Hemp Conference and Expo Published 22nd Jun 2017 | Updated 14th July 2020 Dear Dr. Russo, Thank you for your prompt responses to our communications and for your highly valued knowledge. Kind regards, Nicholas Hill The Hemp Club SOURCE, YOUTUBE: https://www.youtube.com/watch?v=xtphZejvGhk

Read more

UK developer of medical cannabis products raises $345m through share sale

Source: The Pharmaceutical Journal9 OCT 2018By Debbie Andalo UK-based GW Pharmaceuticals has sold almost two million shares in a recent offering on the US stock exchange. Source: GW Pharmaceuticals GW Pharmaceuticals, which has previously marketed cannabis-derived medicines Sativex and Epidiolex, has raised over $345m from share sales in the United States The UK biopharmaceutical company GW Pharmaceuticals, a global developer of

Read more

DEA Green Lights Epidiolex as First Cannabis Derived Pharmaceutical

SOURCE: https://www.newcannabisventures.com/dea-green-lights-epidiolex-as-first-cannabis- September 27, 2018 at 9:22 am Breaking News by Alan Brochstein, CFA The DEA has given Epidiolex, the CBD-based pharmaceutical derived from cannabis that was approved by the FDA for the treatment of rare forms of epilepsy in June, Schedule V status according to the Office of the Federal Register. The developer of the pharmaceutical, GW Pharma (NASDAQ:

Read more